Abstract:Pathogenic hantaviruses, genus Orthohantaviridae, are maintained in rodent reservoirs with zoonotic transmission to humans occurring through inhalation of rodent excreta. Hantavirus disease in humans is characterized by localized vascular leakage and elevated levels of circulating proinflammatory cytokines. Despite the constant potential for deadly zoonotic transmission to humans, specific virus-host interactions of hantaviruses that lead to innate immune activation, and how these processes impart disease, remain unclear. In this study, we examined the mechanisms of viral recognition and innate immune activation of Hantaan orthohantavirus (HTNV) infection. We identified the RIG-I-like receptor (RLR) pathway as essential for innate immune activation, interferon (IFN) production, and interferon stimulated gene (ISG) expression in response to HTNV infection in human endothelial cells, and in murine cells representative of a non-reservoir host. Our results demonstrate that innate immune activation and signaling through the RLR pathway depends on viral replication wherein the host response can significantly restrict replication in target cells in a manner dependent on the type 1 interferon receptor (IFNAR). Importantly, following HTNV infection of a non-reservoir host murine model, IFNAR-deficient mice had higher viral loads, increased persistence, and greater viral dissemination to lung, spleen, and kidney compared to wild-type animals. Surprisingly, this response was MAVS independent in vivo. Innate immune profiling in these tissues demonstrates that HTNV infection triggers expression of IFN-regulated cytokines early during infection. We conclude that the RLR pathway is essential for recognition of HTNV infection to direct innate immune activation and control of viral replication in vitro, and that additional virus sensing and innate immune response pathways of IFN and cytokine regulation contribute to control of HTNV in vivo. These results reveal a critical role for innate immune regulation in driving divergent outcomes of HTNV infection, and serve to inform studies to identify therapeutic targets to alleviate human hantavirus disease.Human pathogenic hantaviruses are endemic in rodent reservoir hosts worldwide. Incidental pathogenic human hantavirus infection has a case-fatality rate of up to 38%. Although Hantaan orthohantavirus (HTNV) is a major cause of human hemorrhagic fevers in Asia, the mechanisms underlying innate immune activation in human target endothelial cells remain unknown. Here, we find that the host cytoplasmic pathogen recognition receptors, RIG-I and MDA5, are essential for induction of antiviral proteins and control of HTNV replication in human and non-reservoir murine cells. Type I interferon, but not type III interferon, is induced in response to live virus infection, and can limit HTNV replication in these cells. We further demonstrate that type I interferon signaling is required for rapid control of virus replication and dissemination in non-reservoir murine hosts in vivo. Importantly, a role for type I interferon-independent mechanisms of antiviral induction in vivo was also revealed. This work provides deeper understanding of how differential host responses to HTNV infection contribute to infection outcomes and is essential to identify targets for therapeutic interventions to mitigate human hantavirus disease.

Viruses Run: The Evasion Mechanisms of the Antiviral Innate Immunity by Hantavirus

Evasion of Antiviral Innate Immunity by Porcine Reproductive and Respiratory Syndrome Virus

Development of Small-Molecule Inhibitors Against Hantaviruses.

Immune response during hantavirus diseases: implications for immunotherapies and vaccine design

STING Strengthens Host Anti-Hantaviral Immunity Through an Interferon-Independent Pathway.

Hantavirus infection: a global zoonotic challenge

The Interaction Between Human Enteroviruses and Type I IFN Signaling Pathway

RIG-I-like receptor activation drives type I IFN and antiviral signaling to limit Hantaan orthohantavirus replication

The interaction between human enteroviruses and type I IFN signaling pathway.

The Evolution and Emergence of Hantaviruses.

The ecological dynamics of hantavirus diseases: From environmental variability to disease prevention largely based on data from China

Hantaan virus inhibits type I interferon response by targeting RLRs signaling pathways through TRIM25

Evasion strategies of porcine reproductive and respiratory syndrome virus

Innate Immunity Evasion Strategies of Highly Pathogenic Coronaviruses: SARS-CoV, MERS-CoV, and SARS-CoV-2

Hantavirus Induced Kidney Disease

HTNV Sensitizes Host Toward TRAIL-Mediated Apoptosis-A Pivotal Anti-hantaviral Role of TRAIL.

The Evolution and Emergence of RNA Viruses

Insight into the Mechanisms of Coronaviruses Evading Host Innate Immunity.

The Role of Long Noncoding RNA Negative Regulator of Interferon Response in the Regulation of Hantaan Virus Infection

Discovery of Hantaviruses in Bats and Insectivores and the Evolution of the Genus Hantavirus.

The Regulatory Network of Cyclic GMP-AMP Synthase-Stimulator of Interferon Genes Pathway in Viral Evasion